| Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy N Polanco, E Gutiérrez, A Covarsí, F Ariza, A Carreño, A Vigil, J Baltar, ... Journal of the American Society of Nephrology 21 (4), 697-704, 2010 | 435 | 2010 |
| Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial F Fakhouri, M Hourmant, JM Campistol, SR Cataland, M Espinosa, ... American journal of kidney diseases 68 (1), 84-93, 2016 | 300 | 2016 |
| An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document JM Campistol, M Arias, G Ariceta, M Blasco, L Espinosa, M Espinosa, ... Nefrología (English Edition) 35 (5), 421-447, 2015 | 245 | 2015 |
| Association of C4d deposition with clinical outcomes in IgA nephropathy M Espinosa, R Ortega, M Sanchez, A Segarra, MT Salcedo, F Gonzalez, ... Clinical Journal of the American Society of Nephrology 9 (5), 897-904, 2014 | 225 | 2014 |
| An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document JM Campistol, M Arias Ballesteros, G Ariceta, M Blasco, M Espinosa, ... Sociedad Española de Nefrología, 2013 | 197 | 2013 |
| Effectiveness of mycophenolate mofetil in C3 glomerulonephritis C Rabasco, T Cavero, E Román, J Rojas-Rivera, T Olea, M Espinosa, ... Kidney international 88 (5), 1153-1160, 2015 | 187 | 2015 |
| A multicentric survey of the practice of hand hygiene in haemodialysis units: factors affecting compliance MD Arenas, J Sánchez-Payá, G Barril, J García-Valdecasas, JL Gorriz, ... Nephrology Dialysis Transplantation 20 (6), 1164-1171, 2005 | 184 | 2005 |
| Mesangial C4d deposition: a new prognostic factor in IgA nephropathy M Espinosa, R Ortega, JM Gómez-Carrasco, F López-Rubio, ... Nephrology Dialysis Transplantation 24 (3), 886-891, 2009 | 174 | 2009 |
| Occult hepatitis C virus infection among hemodialysis patients G Barril, I Castillo, MD Arenas, M Espinosa, J Garcia-Valdecasas, ... Journal of the American Society of Nephrology 19 (12), 2288-2292, 2008 | 152 | 2008 |
| A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome A Huerta, E Arjona, J Portoles, P Lopez-Sanchez, C Rabasco, ... Kidney international 93 (2), 450-459, 2018 | 150 | 2018 |
| Eculizumab in secondary atypical haemolytic uraemic syndrome T Cavero, C Rabasco, A López, E Román, A Ávila, Á Sevillano, A Huerta, ... Nephrology Dialysis Transplantation 32 (3), 466-474, 2017 | 147 | 2017 |
| Risk of death and liver cirrhosis in anti‐HCV‐positive long‐term haemodialysis patients M Espinosa, A Martin‐Malo, MAA de Lara, P Aljama Nephrology Dialysis Transplantation 16 (8), 1669-1674, 2001 | 147 | 2001 |
| The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary … G Fernández-Juárez, J Rojas-Rivera, AE van De Logt, J Justino, ... Kidney international 99 (4), 986-998, 2021 | 138 | 2021 |
| Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences M Espinosa, A Martıén-Malo, R Ojeda, R Santamarıéa, S Soriano, ... American journal of kidney diseases 43 (4), 685-689, 2004 | 126 | 2004 |
| Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies J Luño, V Barrio, MÁ Goicoechea, C González, SG De Vinuesa, F Gómez, ... Kidney International 62, S47-S52, 2002 | 113 | 2002 |
| Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy A Tortajada, E Gutiérrez, EG de Jorge, J Anter, A Segarra, M Espinosa, ... Kidney international 92 (4), 953-963, 2017 | 107 | 2017 |
| High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. M Espinosa, A Martin-Malo, MA Alvarez de Lara, S Soriano, P Aljama Clinical nephrology 54 (2), 151-156, 2000 | 99 | 2000 |
| Complement activation and thrombotic microangiopathies M Palomo, M Blasco, P Molina, M Lozano, M Praga, S Torramade-Moix, ... Clinical Journal of the American Society of Nephrology 14 (12), 1719-1732, 2019 | 74 | 2019 |
| Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome T Cavero, E Arjona, K Soto, F Caravaca-Fontan, C Rabasco, L Bravo, ... Kidney international 96 (4), 995-1004, 2019 | 63 | 2019 |
| Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso JM Campistol, M Arias, G Ariceta, M Blasco, L Espinosa, M Espinosa, ... Nefrología (Madrid) 35 (5), 421-447, 2015 | 63 | 2015 |
